mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.24 |
3e-11 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-07 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-07 |
mRNA |
Bleomycin |
GDSC1000 |
pan-cancer |
AAC |
-0.21 |
2e-07 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.19 |
4e-07 |
mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
2e-06 |
mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
-0.18 |
2e-06 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
3e-06 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-06 |
mRNA |
NVP-BEZ235 |
GDSC1000 |
pan-cancer |
AAC |
-0.18 |
5e-06 |